Hudson Frederick M.
Director at SUPERNUS PHARMACEUTICALS, INC.
- Sold, on record
- $1.2M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Mar 12, 2026
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- SUPERNUS PHARMACEUTICALS, INC.Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice SUPERNUS PHARMACEUTICALS, INC.NoticeNov 14, 2023 2023
Filed to sell 5,211 shares ($147k)
Hudson Frederick M., Director
No 10b5-1 planFirst sale on recordFiling
- 2 Form 144 notice SUPERNUS PHARMACEUTICALS, INC.NoticeNov 15, 2023 +1 day
Filed to sell 3,882 shares ($111k)
Hudson Frederick M., Director
No 10b5-1 planFirst sale on recordFiling
- 3 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.No planNov 15, 2023 same day
Sold 9,093 shares at $28.50 ($259k)
Hudson Frederick M., Director
No 10b5-1 planSold 21.5% of holdings ($1.2M position)33,231 shares leftFirst sale on recordFollows a Form 144Filing
- 4 Form 144 notice SUPERNUS PHARMACEUTICALS, INC.NoticeNov 8, 2024 +359 days
Filed to sell 8,722 shares ($316k)
Hudson Frederick M., Director
No 10b5-1 planFiling
- 5 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.No planNov 8, 2024 same day
Sold 8,722 shares at $36.28 ($316k)
Hudson Frederick M., Director
No 10b5-1 planSold 23.5% of holdings ($1.3M position)28,395 shares leftFollows a Form 144Filing
- 6 Form 144 notice SUPERNUS PHARMACEUTICALS, INC.NoticeAug 14, 2025 +279 days
Filed to sell 7,457 shares ($315k)
Hudson Frederick M., Director
No 10b5-1 planFiling
- 7 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.No planAug 14, 2025 same day
Sold 7,457 shares at $42.26 ($315k)
Hudson Frederick M., Director
No 10b5-1 planSold 13.9% of holdings ($2.3M position)46,307 shares leftFollows a Form 144Filing
- 8 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.No planMar 12, 2026 +210 days
Sold 5,369 shares at $50.61 ($272k)
Hudson Frederick M., Director
No 10b5-1 planSold 8.2% of holdings ($3.3M position)60,413 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | Mar 16, 2026 | SUPERNUS PHARMACEUTICALS, INC. | Director | Form 4 sale | 5,369 | $272k | 8.2% | No plan | SEC |
| Aug 14, 2025 | Aug 18, 2025 | SUPERNUS PHARMACEUTICALS, INC. | Director | Form 4 sale | 7,457 | $315k | 13.9% | No plan | SEC |
| Aug 14, 2025 | Aug 14, 2025 | SUPERNUS PHARMACEUTICALS, INC. | Director | Form 144 notice | 7,457 | $315k | Notice | SEC | |
| Nov 8, 2024 | Nov 12, 2024 | SUPERNUS PHARMACEUTICALS, INC. | Director | Form 4 sale | 8,722 | $316k | 23.5% | No plan | SEC |
| Nov 8, 2024 | Nov 8, 2024 | SUPERNUS PHARMACEUTICALS, INC. | Director | Form 144 notice | 8,722 | $316k | Notice | SEC | |
| Nov 15, 2023 | Nov 17, 2023 | SUPERNUS PHARMACEUTICALS, INC. | Director | Form 4 sale | 9,093 | $259k | 21.5% | No plan | SEC |
| Nov 15, 2023 | Nov 15, 2023 | SUPERNUS PHARMACEUTICALS, INC. | Director | Form 144 notice | 3,882 | $111k | Notice | SEC | |
| Nov 14, 2023 | Nov 14, 2023 | SUPERNUS PHARMACEUTICALS, INC. | Director | Form 144 notice | 5,211 | $147k | Notice | SEC | |
| Jul 13, 2020 | Jul 15, 2020 | SUPERNUS PHARMACEUTICALS, INC. | Director | Form 4 sale | 920 | $22k | 4.9% | Plan not stated | SEC |